Alyeska Investment Group’s Praxis Precision Medicines PRAX Stock Holding History

Alyeska Investment Group’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27.1M	Buy	80,846 +8,668	+12%	+$2.74M	0.07%	296
2026 Q1	$23.3M	Sell	72,178 -2,198	-3%	-$680K	0.07%	304
2025 Q4	$21.9M	Sell	74,376 -67,140	-47%	-$12.5M	0.06%	302
2025 Q3	$7.5M	Buy	141,516 +16,516	+13%	+$801K	0.02%	417
2025 Q2	$5.26M	Sell	125,000 -25,000	-17%	-$952K	0.02%	420
2025 Q1	$5.68M	Sell	150,000 -76,788	-34%	-$4.8M	0.02%	357
2024 Q4	$17.5M	Buy	+226,788	New	+$16.4M	0.07%	274
2024 Q2	–	Sell	-25,000	Closed	-$1.53M	–	655
2024 Q1	$1.53M	Buy	+25,000	New	+$1.12M	0.01%	397
2021 Q3	–	Sell	-5,000	Closed	-$1.37M	–	769
2021 Q2	$1.37M	Buy	+5,000	New	+$1.79M	0.02%	563
2021 Q1	–	Sell	-5,000	Closed	-$4.13M	–	809
2020 Q4	$4.13M	Buy	+5,000	New	+$2.92M	0.06%	307

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Alyeska Investment Group's PRAX Position: Q2 2026 in Review

Alyeska Investment Group increased its Praxis Precision Medicines (PRAX) stake by 12% in Q2 2026, buying an estimated $2.74M and bringing the position to 80,846 shares worth $27.1M. The position accounts for 0.07% of the portfolio, ranked #296.

Alyeska Investment Group first reported a position in PRAX in Q4 2020 and has held it in 10 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Alyeska Investment Group held 80,846 shares of Praxis Precision Medicines worth $27.1M as of Q2 2026.
Alyeska Investment Group bought 8,668 Praxis Precision Medicines shares in Q2 2026, an estimated $2.74M.
Praxis Precision Medicines made up 0.07% of Alyeska Investment Group's portfolio in Q2 2026, its #296 holding.
Alyeska Investment Group first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 10 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.